| [1] Theken KN, Schuck RN, Edin ML,et al.Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease[J].Atherosclerosis,2012,222(2):530-536.[2] Zordoky BN,El-Kadi AO.Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases[J].Pharmacol Ther,2010,125(3):446-463.[3] Wu CC,Schwartzman ML.The role of 20-HETE in androgen-mediated hypertension[J].Prostaglandins Other Lipid Mediat,2011,96(1-4):45-53.[4] Fu Z, Nakayama T, Sato N, et al. Haplotype-based cased-control study of CYP4A11 gene and myocardial infarction[J].Hereditas,2012,149(3):91-98.[5] Sodhi K, Wu CC, Cheng J, et al. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin Ⅱ-dependent[J].Hypertension,2010,56(5):871-878. [6] Ward NC, Rivera J, Hodgson J, et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans[J].Circulation,2004,110(4):438-443. [7] Liu H, Zhao Y, Nie D, et al. Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension[J].J Am Soc Nephrol,2008,19(4):714-721.[8] Ward NC,Tsai IJ,Barden A,et al.A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure[J].Hypertension,2008,51(5):1393-1398.[9] Cheng J, Garcia V, Ding Y, et al. Induction of Angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction[J].Arterioscler Thromb Vasc Biol,2012,32(8):1917-1924.[10] Zeng Q, Han Y, Bao Y, et al. 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes[J].Am J Physiol Heart Circ Physiol,2010,299(4):H1109-H1117.[11] Ward NC,Chen K,Li C,et al.Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction[J].Clin Exp Pharmacol Physiol,2011,38(5):328-333.[12] Cheng J,Wu CC,Gotlinger KH,et al.20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via ikappaB kinase-dependent endothelial nitric-oxide synthase uncoupling[J].J Pharmacol Exp Ther,2010,332(1):57-65.[13] Attwell D,Buchan AM,Charpak S,et al.Glial and neuronal control of brain blood flow[J].Nature,2010,468(7321):232-243.[14] 程海花,阿祥仁,王立萍.不同海拔地区健康人群血管内皮细胞功能指标的变化[J].检验医学,2010,25(8):647-648.[15] Tunctan B,Korkmaz B,Cuez T,et al.Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor,NS-398,on endotoxin-induced hypotension in rats[J].Basic Clin Pharmacol Toxicol,2010,107(5):877-882.[16] Kompanowska-Jezierska E,Kuczeriszka M.Cytochrome P- 450 metabolites in renal circulation and excretion-interaction with the nitric oxide(NO)system[J].J Physiol Pharmacol,2008,59(Suppl 9):137-149.[17] Calabrese V, Cornelius C, Rizzarelli E, et al. Nitric oxide in cell survival:a janus molecule[J].Antioxid Redox Signal,2009,11(11):2717-2739.[18] Dhanasekaran A, Bodiga S, Gruenloh S, et al. 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells[J].Am J Physiol Heart Circ Physiol,2009,296(3):H777-H786.[19] Harrison DG, Gongora MC. Oxidative stress and hypertension[J].Med Clin North Am,2009,93(3):621-635.[20] Toda N,Ayajiki K,Okamura T.Interaction of endothelial nitric oxide and angiotensin in the circulation[J].Pharmacol Rev,2007,59(1):54-87.[21] Williams JM, Murphy S, Burke M, et al. 20-hydr-oxyeicosatetraeonic acid:a new target for the treatment of hypertension[J].J Cardiovasc Pharmacol,2010,56(4):336-344.[22] Tsai IJ, Croft KD, Puddey IB,et al. 20-Hydroxyei-cosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin Ⅱ and endothelin-1[J].Am J Physiol Heart Circ Physiol,2011,300(4):H1194-H1200. [23] Kuczeriszka M,Olszyński KH,Gasiorowska A,et al.Interaction of nitric oxide and the cytochrome P- 450 system on blood pressure and renal function in the rat:dependence on sodium intake[J].Acta Physiol(Oxf),2011,201(4):493-502.[24] Yanes LL,Lima R,Moulana M,et al.Postmenopausal hypertension:role of 20-HETE[J].Am J Physiol Requl Inteqr Comp Physiol,2011,300(6):R1543-R1548.[25] Ward NC,Hodqson JM,Puddey IB,et al.20-hydroxyei-cosatetraenoic acid is not associated with circulating insulin in lean to overweight humans[J].Diabetes Res Clin Pract,2006,74(2):197-200.[26] Blewett AJ,Varma D,Gilles T,et al.Development and validation of a high-performance liquid chromatography-electrospray mass spectrometry method for the simultaneous determination of 23 eicosanoids[J].J Pharm Biomed Anal,2008,46(4):653-662. [27] Alexanian A,Miller B,Roman RJ,et al.20-HETE-producing enzymes are up-regulated in human cancers[J].Cancer Genomics Proteomics,2012,9(4):163-169.[28] Mu Y, Klamerus MM, Miller TM, et al. Intravenous formulation of N-hydroxy-N′-(4-n-butyl-2-methylphenyl) formamiddine(HET0016)for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation[J].Drug Metab Dispos,2008,36(11):2324-2330. |
